Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days

PURPOSE: Co-administration of the 5α-reductase inhibitor dutasteride increases the oral testosterone bioavailability in men with experimentally induced hypogonadism. We examined oral testosterone with and without dutasteride administration in hypogonadal men for 28 days. MATERIALS AND METHODS: We ra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Urol
Egile Nagusiak: Amory, John K., Bush, Mark A., Zhi, Hui, Caricofe, Ralph B., Matsumoto, Alvin M., Swerdloff, Ronald S., Wang, Christina, Clark, Richard V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267472/
https://ncbi.nlm.nih.gov/pubmed/21168874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.09.089
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak